These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4723268)

  • 1. Pharmacokinetics and metabolism of adriamycin in man.
    Benjamin RS; Riggs CE; Bachur NR
    Clin Pharmacol Ther; 1973; 14(4):592-600. PubMed ID: 4723268
    [No Abstract]   [Full Text] [Related]  

  • 2. [The pharmacokinetics of adriamycin and adriamycin-metabolites (author's transl)].
    Ehninger G; Stocker HJ; Proksch B; Wilms K
    Klin Wochenschr; 1980 Sep; 58(18):927-34. PubMed ID: 7206588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of 4'-epi-doxorubicin in man.
    Weenen H; Lankelma J; Penders PG; McVie JG; ten Bokkel Huinink WW; de Planque MM; Pinedo HM
    Invest New Drugs; 1983; 1(1):59-64. PubMed ID: 6590528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of whole-body hyperthermia on the disposition and metabolism of adriamycin in rabbits.
    Mimnaugh EG; Waring RW; Sikic BI; Magin RL; Drew R; Litterst CL; Gram TE; Guarino AM
    Cancer Res; 1978 May; 38(5):1420-5. PubMed ID: 639069
    [No Abstract]   [Full Text] [Related]  

  • 5. Adriamycin metabolism in man. Evidence from urinary metabolites.
    Takanashi S; Bachur NR
    Drug Metab Dispos; 1976; 4(1):79-87. PubMed ID: 3405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilary disposition of adriamycin.
    Riggs CE; Benjamin RS; Serpick AA; Bachur NR
    Clin Pharmacol Ther; 1977 Aug; 22(2):234-41. PubMed ID: 884924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function.
    Benjamin RS; Riggs CE; Bachur NR
    Cancer Res; 1977 May; 37(5):1416-20. PubMed ID: 856462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution and excretion of adriamycin in man.
    Di Fronzo G; Lenaz L; Bonadonna G
    Biomedicine; 1973 Apr; 19(4):169-71. PubMed ID: 4715577
    [No Abstract]   [Full Text] [Related]  

  • 9. Study of doxorubicin photodegradation in plasma, urine and cell culture medium by HPLC.
    Le Bot MA; Riche C; Guedes Y; Kernaleguen D; Simon S; Begue JM; Berthou F
    Biomed Chromatogr; 1988 Nov; 2(6):242-4. PubMed ID: 3233392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma pharmacokinetics of adriamycin after intrapleural administration.
    Eksborg S; Lindfors A; Cedermark BJ
    Med Oncol Tumor Pharmacother; 1984; 1(3):193-4. PubMed ID: 6544898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule.
    Benjamin RS; Wiernik PH; Bachur NR
    Cancer; 1974 Jan; 33(1):19-27. PubMed ID: 4810094
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols.
    Greene RF; Collins JM; Jenkins JF; Speyer JL; Myers CE
    Cancer Res; 1983 Jul; 43(7):3417-21. PubMed ID: 6850648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin pharmacokinetics--the effects of protein deprivation.
    Kapelanski DP; Daly JM; Copeland EM; Dudrick SJ
    J Surg Res; 1981 Apr; 30(4):331-7. PubMed ID: 6785527
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative pharmacokinetics and metabolism of doxorubicin and epirubicin in patients with metastatic breast cancer.
    Robert J; Vrignaud P; Nguyen-Ngoc T; Iliadis A; Mauriac L; Hurteloup P
    Cancer Treat Rep; 1985 Jun; 69(6):633-40. PubMed ID: 3893693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography.
    Andrews PA; Brenner DE; Chou FT; Kubo H; Bachur NR
    Drug Metab Dispos; 1980; 8(3):152-6. PubMed ID: 6104578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid analytic method for adriamycin and metabolites in human plasma by a thin-film fluorescence scanner.
    Watson E; Chan KK
    Cancer Treat Rep; 1976 Nov; 60(11):1611-8. PubMed ID: 1035506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic efficiency of adriamycin in mice, bearing transplanted or autochthonous solid tumors. Drug and fluorescent metabolites plasmatic levels (author's transl)].
    Denechaud M; Laval M; Robert J; Ducassou D
    Bull Cancer; 1981; 68(4):313-20. PubMed ID: 6797492
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacokinetic study of adriamycin in dogs and rabbits, in the absence of a carrier].
    Frutos G; Cadórniga R; Bellido V; Llorente L; Martín P
    Rev Esp Oncol; 1982; 29(4):623-32. PubMed ID: 6927367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetic study of adriamycin in dogs. The problem of parameter calculations].
    Frutos G; Cadórniga R; Martín P; Bellido V
    Rev Esp Oncol; 1982; 29(2):269-81. PubMed ID: 7188230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of possible dose-dependent doxorubicin plasma kinetics in man.
    Boston RC; Phillips DR
    Cancer Treat Rep; 1983 Jan; 67(1):63-9. PubMed ID: 6616493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.